We have tested for production of caseinolytic activity the strain of E. coli K12 J62 carrying different R factors from various Enterobacteriaceae of clinical isolates. The results obtained showed the presence of a caseinolytic activity in 7 out of 139 R factors tested. All of these positive (cas+) R factors derived from strains of Klebsiella pneumoniae and all were able to transfer a strong lac+ phenotype as well as multiple antibiotic resistances (R-lac factors). Another strain of E. coli K12, J53, which is plasmid-free, produced levels of caseinolytic activity comparable to those of the Klebsiella R factors; J62, on the contrary, appeared to possess an inhibitor specific for the caseinolytic activities of J53 and of the R factors but not of other cas+ Gram+ and Gram- organisms. The hypothesis that the expression of the cas+ phenotype in E. coli K12 may be due to the presence of plasmid-linked regulatory genes is discussed.

A plasmid-linked caseinolytic activity in Enterobacteriaceae.

PAGANI, LAURA;ROMERO, EGIDIO
1983-01-01

Abstract

We have tested for production of caseinolytic activity the strain of E. coli K12 J62 carrying different R factors from various Enterobacteriaceae of clinical isolates. The results obtained showed the presence of a caseinolytic activity in 7 out of 139 R factors tested. All of these positive (cas+) R factors derived from strains of Klebsiella pneumoniae and all were able to transfer a strong lac+ phenotype as well as multiple antibiotic resistances (R-lac factors). Another strain of E. coli K12, J53, which is plasmid-free, produced levels of caseinolytic activity comparable to those of the Klebsiella R factors; J62, on the contrary, appeared to possess an inhibitor specific for the caseinolytic activities of J53 and of the R factors but not of other cas+ Gram+ and Gram- organisms. The hypothesis that the expression of the cas+ phenotype in E. coli K12 may be due to the presence of plasmid-linked regulatory genes is discussed.
1983
Microbiology covers the biology and biochemistry of microorganisms, bacterial, viral, and parasitic, as well as the medical implications and treatments of the subset of these organisms known to cause disease in humans and/or animals. Biotechnology applications of microorganisms for basic science or clinical use are also covered. Resources that emphasize immune response to pathogens and its modulation by clinical intervention are excluded and are covered in the Immunology category.
Sì, ma tipo non specificato
Italiano
Nazionale
STAMPA
6
229
237
Caseins; metabolism, Enterobacteriaceae; enzymology/genetics, Escherichia coli; enzymology, Genes; Bacterial, Genes; Regulator, Genetic Linkage, Klebsiella pneumoniae; enzymology, Peptide Hydrolases; genetics, R Factors
3
info:eu-repo/semantics/article
262
P., Mignatti; Pagani, Laura; Romero, Egidio
1 Contributo su Rivista::1.1 Articolo in rivista
none
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11571/444261
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact